| Abstract: | The release of hazardous substances is a matter of concern for nanotechnology. This may include some nanoparticles, reactants, by‐products, and solvents. The use of low‐hazard solvents may reduce the hazards from nanoparticle production and nanomaterial processing. The hazards of inorganic nanoparticles may be reduced by modifying their chemical composition, surface characteristics, or structure. In nanomedicine, optimizing the balance between persistence and excretion and preventing the release of toxic degradation products may reduce hazard. In applications of fixed inorganic nanoparticles, the focus should be on preventing the release of such particles and of hazardous compounds during the product life cycle. When, after exhaustion of known hazard reduction options, significant hazard remains, other approaches merit consideration. |
